{"id":2302,"date":"2014-11-01T12:07:00","date_gmt":"2014-11-01T11:07:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2014\/der-physician-payment-sunshine-act-in-den-usa-erste-ergebnisse"},"modified":"2014-11-01T12:07:00","modified_gmt":"2014-11-01T11:07:00","slug":"der-physician-payment-sunshine-act-in-den-usa-erste-ergebnisse","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2014\/der-physician-payment-sunshine-act-in-den-usa-erste-ergebnisse","title":{"rendered":"Der Physician Payment Sunshine Act in den USA \u2013 erste Ergebnisse"},"content":{"rendered":"<p>Hat mein Arzt Geld von pharmazeutischen Unternehmern (pU) angenommen? Wenn ja, wieviel? Seit dem 30. September 2014 k\u00f6nnen Patienten und andere Interessierte diese Frage f\u00fcr alle \u00c4rzte mit einer US-amerikanischen Zulassung recherchieren, im Rahmen des &#8222;Open payments&#8220;-Programms. Grundlage ist der &#8222;Physician Payment Sunshine Act&#8220;, ein 2012 in den USA verabschiedetes Gesetz, das darauf abzielt, die [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Hat mein Arzt Geld von pharmazeutischen Unternehmern (pU) angenommen? Wenn ja, wieviel? Seit dem 30. September 2014 k\u00f6nnen Patienten und andere Interessierte diese Frage f\u00fcr alle \u00c4rzte mit einer US-amerikanischen Zulassung recherchieren, im Rahmen des &#8222;Open payments&#8220;-Programms. Grundlage ist der &#8222;Physician Payment Sunshine Act&#8220;, ein 2012 in den USA verabschiedetes Gesetz, das darauf abzielt, die [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[255,1451,4581,3043,3042,1452,257,843,846,3261,2319,4580,1561],"class_list":["post-2302","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-arzneimittel","tag-bias","tag-centers-for-medicare-medicaid-services","tag-freiwillige-selbstkontrolle","tag-fsa","tag-interessenkonflikte","tag-medikamente","tag-pharmaindustrie","tag-pharmazeutische-unternehmer","tag-physician-payment-sunshine-act","tag-transparenz","tag-transparenzkodex","tag-werbung"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/2302","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=2302"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/2302\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=2302"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=2302"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=2302"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}